ClearFlow | Improve Cardiac Surgery Outcomes
Company Details
Status: Private
Employees: 11-50
Location:
16 Technology Dr, Suite 150, Irvine, California 92618, US
Type:
sample
Technology:
sample
About: ClearFlow, Inc. is a medical device company that specializes in innovative surgical drainage solutions. Founded in 2007 by cardiothoracic surgeons Dr. Edward Boyle and Dr. Marc Gillinov, the company focuses on improving outcomes in cardiac surgery by addressing complications related to retained blood and fluids after surgery.
The company's primary offering is the PleuraFlow Active Tube Clearance System, a chest tube designed with Active Clearance Technology (ACT). This system helps maintain patency and prevent occlusions, reducing the risk of "failure to drain" events that can lead to longer hospital stays and increased costs. ClearFlow's products are targeted at hospitals and healthcare facilities performing cardiothoracic surgeries, particularly in intensive care units.
Led by President and CEO Paul Molloy, ClearFlow is committed to developing devices that enhance patient recovery and reduce healthcare costs. The company has received FDA 510(k) clearance and the CE Mark for its PleuraFlow system, reflecting its dedication to providing reliable solutions for clinicians.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
ClearFlow | Improve Cardiac Surgery Outcomes | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.